Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Taixiong Xue"'
Autor:
Qun Wei, Cailing Gan, Meng Sun, Yuting Xie, Hongyao Liu, Taixiong Xue, Conghui Deng, Chunheng Mo, Tinghong Ye
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-30 (2024)
Abstract Fibrosis is an excessive wound-healing response induced by repeated or chronic external stimuli to tissues, significantly impacting quality of life and primarily contributing to organ failure. Organ fibrosis is reported to cause 45% of all-c
Externí odkaz:
https://doaj.org/article/3b69c5d2e6cb4cce925f11611ff9ec65
Autor:
Zui Tan, Hongbao Sun, Taixiong Xue, Cailing Gan, Hongyao Liu, Yuting Xie, Yuqin Yao, Tinghong Ye
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Liver fibrosis is an abnormal wound repair response caused by a variety of chronic liver injuries, which is characterized by over-deposition of diffuse extracellular matrix (ECM) and anomalous hyperplasia of connective tissue, and it may further deve
Externí odkaz:
https://doaj.org/article/1a257aab5d2044be8d2387b29be0facd
Autor:
Chen Fan, Yijie Wang, Hui Huang, Wenzhen Li, Jialin Ma, Dongping Yao, Zijun Tang, Taixiong Xue, Liyang Ha, Yan Ren, Yiwen Zhang, Qin Wang, Yongmei Xie, Yi Luo, Rui Tan, Jian Gu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Breast cancer is the most common malignancy in women and is a molecularly heterogeneous disease. Signal transducer and activator of transcription 3 (Stat3) is overexpressed and hyperactivated in a variety of human tumours, including breast cancer, th
Externí odkaz:
https://doaj.org/article/79f04a661af54a0b8ddfc0fa30a09430
Autor:
Yuting Xie, Lin Yue, Yaojie Shi, Xingping Su, Cailing Gan, Hongyao Liu, Taixiong Xue, Tinghong Ye
Publikováno v:
Journal of Medicinal Chemistry. 66:4342-4360
Autor:
Taixiong Xue, Lin Yue, Guonian Zhu, Zui Tan, Hongyao Liu, Cailing Gan, Chen Fan, Xingping Su, Yuting Xie, Tinghong Ye
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver.
Liver fibrosis is an excessive wound-healing response governed by activated hepatic stellate cells (HSCs). To date, there is no drug available for liver fibrosis. Although ferulic acid (FA) has multiple pharmacological functions, its anti-hepatic fib
Autor:
Yijie Wang, Hongyao Liu, Wenzhen Li, Yuting Xie, Cailing Gan, Taixiong Xue, Xingping Su, Lin Yue, Qin Wang, Chen Fan, Yiwen Zhang, Tinghong Ye
Publikováno v:
European journal of medicinal chemistry. 246
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease of unknown aetiology with limited treatment options. Currently, only two drugs, nintedanib and pirfenidone, are approved for the clinical treatment of IPF, but their efficacie
Autor:
Hongyao Liu, Yan Yu, Taixiong Xue, Cailing Gan, Yuting Xie, Doudou Wang, Peilin Li, Zhiyong Qian, Tinghong Ye
Publikováno v:
Chinese Chemical Letters. :108574
Autor:
Lin, Yue, Taixiong, Xue, Xingping, Su, Zhihao, Liu, Hongyao, Liu, Zui, Tan, Cailing, Gan, Yuting, Xie, Tinghong, Ye
Publikováno v:
European Journal of Medicinal Chemistry. 242:114685
Liver fibrosis is characterized by the excessive deposition of extracellular matrix components and results from chronic liver injury. At present, there is no approved drug for the treatment of liver fibrosis by the Food and Drug Administration. Here,
Autor:
Tinghong Ye, Yuqin Yao, Zui Tan, Yuting Xie, Hongbao Sun, Hongyao Liu, Cailing Gan, Taixiong Xue
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
Liver fibrosis is an abnormal wound repair response caused by a variety of chronic liver injuries, which is characterized by over-deposition of diffuse extracellular matrix (ECM) and anomalous hyperplasia of connective tissue, and it may further deve
Autor:
Taixiong Xue, Chen Fan, Yan Ren, Jian Gu, Dongping Yao, Hui Huang, Jialin Ma, Yijie Wang, Yi Luo, Yiwen Zhang, Rui Tan, Liyang Ha, Qin Wang, Zijun Tang, Wenzhen Li, Yongmei Xie
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Breast cancer is the most common malignancy in women and is a molecularly heterogeneous disease. Signal transducer and activator of transcription 3 (Stat3) is overexpressed and hyperactivated in a variety of human tumours, including breast cancer, th